Yamaguchi H, Nagamura Y, Miyazaki M
Cancers (Basel). 2022; 14(15).
PMID: 35954414
PMC: 9367326.
DOI: 10.3390/cancers14153750.
Shirakihara T, Yamaguchi H, Kondo T, Yashiro M, Sakai R
Oncogene. 2022; 41(18):2587-2596.
PMID: 35338344
DOI: 10.1038/s41388-022-02270-5.
Georgescu M, Islam M, Li Y, Traylor J, Nanda A
Acta Neuropathol Commun. 2021; 9(1):69.
PMID: 33853673
PMC: 8048363.
DOI: 10.1186/s40478-021-01170-1.
Zhang J, Tang P, Zhou Y, Cheng A, Yu J, Kang W
Cells. 2019; 8(6).
PMID: 31242658
PMC: 6627225.
DOI: 10.3390/cells8060637.
Tirino G, Pompella L, Petrillo A, Laterza M, Pappalardo A, Caterino M
Int J Mol Sci. 2018; 19(9).
PMID: 30205505
PMC: 6165492.
DOI: 10.3390/ijms19092659.
Generation of high-affinity, internalizing anti-FGFR2 single-chain variable antibody fragment fused with Fc for targeting gastrointestinal cancers.
Borek A, Sokolowska-Wedzina A, Chodaczek G, Otlewski J
PLoS One. 2018; 13(2):e0192194.
PMID: 29420662
PMC: 5805272.
DOI: 10.1371/journal.pone.0192194.
Molecular heterogeneity in the novel fusion gene : Diversity of genomic breakpoints in gastric cancer with high-level amplifications at 11p13 and 10q26.
Okuda T, Taki T, Nishida K, Chinen Y, Nagoshi H, Sakakura C
Oncol Lett. 2017; 13(1):215-221.
PMID: 28123544
PMC: 5244987.
DOI: 10.3892/ol.2016.5386.
Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer.
Nadauld L, Garcia S, Natsoulis G, Bell J, Miotke L, Hopmans E
Genome Biol. 2014; 15(8):428.
PMID: 25315765
PMC: 4145231.
DOI: 10.1186/s13059-014-0428-9.
FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study.
Su X, Zhan P, Gavine P, Morgan S, Womack C, Ni X
Br J Cancer. 2014; 110(4):967-75.
PMID: 24457912
PMC: 3929881.
DOI: 10.1038/bjc.2013.802.
Enhanced expression of long non-coding RNA HOTAIR is associated with the development of gastric cancer.
Endo H, Shiroki T, Nakagawa T, Yokoyama M, Tamai K, Yamanami H
PLoS One. 2013; 8(10):e77070.
PMID: 24130837
PMC: 3795022.
DOI: 10.1371/journal.pone.0077070.
Quantitative and Sensitive Detection of Cancer Genome Amplifications from Formalin Fixed Paraffin Embedded Tumors with Droplet Digital PCR.
Nadauld L, Regan J, Miotke L, Pai R, Longacre T, Kwok S
Transl Med (Sunnyvale). 2013; 2(2).
PMID: 23682346
PMC: 3653435.
DOI: 10.4172/2161-1025.1000107.
Clinical significance of keratinocyte growth factor and K-sam gene expression in gastric cancer.
Tani H, Saito N, Kobayashi M, Kameoka S
Mol Med Rep. 2013; 7(5):1381-6.
PMID: 23545898
PMC: 3658850.
DOI: 10.3892/mmr.2013.1397.
Molecular targeted therapies in advanced gastric cancer: does tumor histology matter?.
Wong H, Yau T
Therap Adv Gastroenterol. 2013; 6(1):15-31.
PMID: 23320047
PMC: 3539290.
DOI: 10.1177/1756283X12453636.
Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications.
Yamashita K, Sakuramoto S, Watanabe M
Surg Today. 2010; 41(1):24-38.
PMID: 21191688
DOI: 10.1007/s00595-010-4370-5.
Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence.
Walch A, Zitzelsberger H, Bruch J, Keller G, Angermeier D, Aubele M
Am J Pathol. 2000; 156(2):555-66.
PMID: 10666385
PMC: 1850031.
DOI: 10.1016/S0002-9440(10)64760-8.
Chromosome band 16q24 is frequently deleted in human gastric cancer.
Mori Y, Matsunaga M, Abe T, Fukushige S, Miura K, Sunamura M
Br J Cancer. 1999; 80(3-4):556-62.
PMID: 10408866
PMC: 2362314.
DOI: 10.1038/sj.bjc.6690391.
Deletion mapping on chromosome 1p in well-differentiated gastric cancer.
Ezaki T, Yanagisawa A, Ohta K, Aiso S, Watanabe M, Hibi T
Br J Cancer. 1996; 73(4):424-8.
PMID: 8595154
PMC: 2074468.
DOI: 10.1038/bjc.1996.76.
Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice.
Yashiro M, Chung Y, Nishimura S, Inoue T, Sowa M
Clin Exp Metastasis. 1996; 14(1):43-54.
PMID: 8521616
DOI: 10.1007/BF00157685.
Infrequent ras mutation in human stomach cancers.
Koshiba M, Ogawa O, Habuchi T, Hamazaki S, Shimada T, Takahashi R
Jpn J Cancer Res. 1993; 84(2):163-7.
PMID: 8463133
PMC: 5919135.
DOI: 10.1111/j.1349-7006.1993.tb02850.x.
Molecular mechanism of stomach carcinogenesis.
Tahara E
J Cancer Res Clin Oncol. 1993; 119(5):265-72.
PMID: 8440743
DOI: 10.1007/BF01212724.